Patents
US 10314792 B2: Treatment of autism with cannabidiol
- Granted
- 2019-06-11
- Filed
- 2018-12-14 application 16220249
- Type
- Utility · 7 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present technology relates to a method of treating one or more behavioral symptoms of Autism Spectrum Disorder (ASD) in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of ASD are treated in the subject.
Source: PVGPATDIS, file of 2026-04-10 (ipg190611.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. 13 patents | US company or organization | Devon, PA | ZYNERBA PHARMACEUTICALS, INC. Federal lobbying client EXACT high confidence: identical full name and state ZYNERBA PHARMACEUTICALS, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Terri Sebree | Gladwyne, PA | 27 | PVGPATDIS, file of 2026-04-10 | |
| Marcel Bonn-Miller | Lexington, NC | 10 | PVGPATDIS, file of 2026-04-10 | |
| Donna Gutterman | Raleigh, NC | 14 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/658 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P25/00 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2026-05-18 | Correction Supplemental confirmatory grant of security interest in united states patents | HARMONY BIOSCIENCES MANAGEMENT, INC. (F/K/A ZYNERBA PHARMACEUTICALS, INC.) signed 2026-05-04 | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT CHICAGO, IL | 75642/639 | PASDL, file of 2026-10-15 |
| 2019-10-17 | Government interest Confirmatory assignment | SEBREE, TERRI signed 2019-05-20 GUTTERMAN, DONNA signed 2019-05-21 BONN-MILLER, MARCEL signed 2019-07-09 | ZYNERBA PHARMACEUTICALS, INC. DEVON, PA | 50748/699 | ECORSEXC, file of 2026-09-25 |
| 2019-02-13 | Assignment Assignment of assignor's interest | GUTTERMAN, DONNA signed 2018-09-25 MESSENHEIMER, JOHN signed 2018-09-25 SEBREE, TERRI signed 2018-09-26 TICH, NANCY signed 2018-09-26 BONN-MILLER, MARCEL signed 2018-09-30 | ZYNERBA PHARMACEUTICALS, INC. DEVON, PA | 48318/477 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.